Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(145 Videos)

Education
(9 Videos)
Innovation
(0 Videos)
Leadership
(3 Videos)
OrthoJoe
(21 Videos)
Other
(14 Videos)
Personal Growth
(1 Videos)
Practice
(2 Videos)
Research
(19 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Region of the Body

See all (5)

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 7 results matching your search query: "GlaxoSmithKline"

Showing 1 - 7 of 7
Read Ace Report

Effect of tranexamic acid and indirect factor Xa inhibitor on blood loss and DVT after TKA

Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2611-7

RCT Arthroplasty Lower Extremity Knee GlaxoSmithKline Fondaparinux Tranexamic Acid Blood Loss Factor Implantation Inhibitor TKA Surgery Tourniquet Release - Hide
Read Ace Report

Late PONV reduced with ramosetron vs ondansetron following TKA under spinal anesthesia

J Arthroplasty. 2017 Mar;32(3):1040-1043

RCT Arthroplasty Osteoarthritis Axial Skeleton Spine Lower Extremity Knee Arthritis Astellas GlaxoSmithKline Ondansetron Metoclopramide Anaesthesia Intrathecal Morphine Ramosetron Spinal Anesthesia - Hide
Read Ace Report

Denosumab reduces secondary fragility fracture risk in osteoporotic women

Climacteric. 2015 Jun 1:1-23

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Fracture Amgen GlaxoSmithKline Denosumab Placebo Subcutaneous Injections - Hide
Read Ace Report

Is chemical thromboprophylaxis necessary following total hip replacement?

J Bone Joint Surg Br. 2011 Feb;93(2):251-6

RCT Arthroplasty Thromboembolism Lower Extremity Hip Aventis GlaxoSmithKline Sanofi Enoxaparin Fondaparinux Mechanical Stimulation Prophylactic Replacement Thromboprophylaxis - Hide
Read Ace Report

Ronacaleret does not significantly reduce time to healing of distal radius fracture

Bone. 2011 Oct;49(4):845-52. doi: 10.1016/j.bone.2011.06.017. Epub 2011 Jun 30

RCT General Orthopaedics Bone Radius Fracture GlaxoSmithKline Quest Diagnostics Calcium Placebo Ronacaleret - Hide
Read Ace Report

Teriparatide increases BMD in patients with glucocorticoid-Induced osteoporosis

N Engl J Med. 2007 Nov 15;357(20):2028-39

RCT Metabolic Disorders Osteoporosis Amgen Aventis Eli Lilly GlaxoSmithKline Merck Novartis Roche Alendronate Glucocorticoid Teriparatide Injectable Oral Placebo - Hide
Read Ace Report

Denosumab reduces risk of fractures in post-menopausal women

N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Axial Skeleton Spine Spine Lumbar Fracture Amgen AstraZeneca Aventis Eli Lilly GlaxoSmithKline Merck Nordic Bioscience Novartis Procter & Gamble Roche Sanofi Denosumab Placebo Subcutaneous Injection - Hide
Showing 1 - 7 of 7